Yayın:
Study design and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide (ALAFOS)

dc.contributor.authorChen, Chung Hwan
dc.contributor.authorAlsalmawy, A.
dc.contributor.authorIsh, S. Shalom
dc.contributor.authorLim, S. J.
dc.contributor.authorAl, N. Ali
dc.contributor.authorCunha, J. L. Borges
dc.contributor.authorYang, H.
dc.contributor.authorCasas, N.
dc.contributor.authorMoll, T.
dc.contributor.authorGürbüz, Sirel
dc.contributor.authorBrnabic, A. J. M.
dc.contributor.authorMarin, F.
dc.contributor.buuauthorAltan, Lale
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFiziksel Tıp ve Rehabilitasyon Ana Bilim Dalı
dc.contributor.departmentRomatoloji Bilim Dalı
dc.contributor.researcheridAAH-1652-2021
dc.date.accessioned2023-11-23T08:35:29Z
dc.date.available2023-11-23T08:35:29Z
dc.date.issued2018-04
dc.descriptionBu çalışma, 19-22 Nisan 2018 tarihlerinde Krakow[Polonya]’da düzenlenen WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipWCO
dc.description.sponsorshipInt Osteoporosis Fdn
dc.description.sponsorshipEuropean Soc Clin & Econ Aspects Osteoporosis, Osteoarthritis & Musculoskeletal Dis
dc.description.sponsorshipSinklar Conf Management B V
dc.description.sponsorshipMylan
dc.description.sponsorshipLilly
dc.description.sponsorshipUCB
dc.description.sponsorshipMedimaps
dc.description.sponsorshipOsteoSys
dc.description.sponsorshipEcholight
dc.description.sponsorshipAbiogen Pharma
dc.description.sponsorshipPierre Fabre
dc.description.sponsorshipBioventus
dc.description.sponsorshipAmgen
dc.description.sponsorshipIBSA
dc.description.sponsorshipMedi
dc.description.sponsorshipKyowa Kirin
dc.description.sponsorshipWisepress Com
dc.description.sponsorshipEffRx
dc.description.sponsorshipAlexion
dc.description.sponsorshipHologic
dc.description.sponsorshipGE
dc.description.sponsorshipGalgo Med
dc.description.sponsorshipBindex
dc.description.sponsorshipAgNovos
dc.description.sponsorshipTheramex
dc.description.sponsorshipFidia Pharma Grp
dc.description.sponsorshipBiomedica
dc.description.sponsorshipRadius
dc.description.sponsorshipRoche
dc.description.sponsorshipSequola
dc.description.sponsorshipEli Lilly
dc.identifier.citationChen, C. H. vd. (2018). ''Study design and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide (ALAFOS)''. Osteoporosis International, 29(Supplement 1), S298-S299.
dc.identifier.endpageS299
dc.identifier.issn0937-941X
dc.identifier.issn1433-2965
dc.identifier.issueSupplement 1
dc.identifier.startpageS298
dc.identifier.urihttps://www.springer.com/journal/198
dc.identifier.urihttp://hdl.handle.net/11452/34990
dc.identifier.volume29
dc.identifier.wos000440102402124
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherSpringer
dc.relation.collaborationYurt dışı
dc.relation.collaborationSanayi
dc.relation.journalOsteoporosis International
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectEndocrinology & metabolism
dc.subject.wosEndocrinology & metabolism
dc.titleStudy design and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide (ALAFOS)
dc.typeOther
dc.type.subtypeMeeting Abstract
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Fiziksel Tıp ve Rehabilitasyon Ana Bilim Dalı/Romatoloji Bilim Dalı
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama